Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)

Suji Han; Hyemi Shin; Jin Ku Lee; Zhaoqi Liu; Raul Rabadan; Jeongwu Lee; Jihye Shin; Cheolju Lee; Heekyoung Yang; Donggeon Kim; Sung Heon Kim; Jooyeon Kim; Jeong Woo Oh; Doo Sik Kong; Jung Il Lee; Ho Jun Seol; Jung Won Choi; Hyun Ju Kang; Do Hyun Nam

doi:10.1038/s12276-020-00517-3

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)

Suji Han
, Hyemi Shin
, Jin Ku Lee
, Zhaoqi Liu
, Raul Rabadan
, Jeongwu Lee
, Jihye Shin
, Cheolju Lee
, Heekyoung Yang
, Donggeon Kim
, Sung Heon Kim
, Jooyeon Kim
, Jeong Woo Oh
, Doo Sik Kong
, Jung Il Lee
, Ho Jun Seol
, Jung Won Choi
, Hyun Ju Kang
, Do Hyun Nam

Department of Neurosurgery

Sungkyunkwan University
Ajou University
Columbia University
Cleveland Clinic Foundation
Korea Institute of Science and Technology
University of Science and Technology UST

Research output: Contribution to journal › Comment/debate

Abstract

After online publication of this article, the authors noticed an error in the Acknowledgments section. The correct statement in this article should have read as follows. “The biospecimens for this study were provided by the Samsung Medical Center BioBank. This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3418); the National Research Foundation funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea (NRF-2015M3C9A1044522 and NRF-2018R1C1B3001648); and the intramural research fund of Ajou University Medical Center (2018).” The authors apologize for any inconvenience caused.

Original language	English
Pages (from-to)	1869
Number of pages	1
Journal	Experimental and Molecular Medicine
Volume	52
Issue number	11
DOIs	https://doi.org/10.1038/s12276-020-00517-3
State	Published - Nov 2020

Access to Document

10.1038/s12276-020-00517-3

Cite this

Han, S., Shin, H., Lee, J. K., Liu, Z., Rabadan, R., Lee, J., Shin, J., Lee, C., Yang, H., Kim, D., Kim, S. H., Kim, J., Oh, J. W., Kong, D. S., Lee, J. I., Seol, H. J., Choi, J. W., Kang, H. J., & Nam, D. H. (2020). Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y). Experimental and Molecular Medicine, 52(11), 1869. https://doi.org/10.1038/s12276-020-00517-3

@article{c350442c161c4653a7dcb57536b00083,

title = "Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental \& Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)",

abstract = "After online publication of this article, the authors noticed an error in the Acknowledgments section. The correct statement in this article should have read as follows. {\textquotedblleft}The biospecimens for this study were provided by the Samsung Medical Center BioBank. This research was supported by grants from the Korea Health Technology R\&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health \& Welfare, Republic of Korea (HI14C3418); the National Research Foundation funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea (NRF-2015M3C9A1044522 and NRF-2018R1C1B3001648); and the intramural research fund of Ajou University Medical Center (2018).{\textquotedblright} The authors apologize for any inconvenience caused.",

author = "Suji Han and Hyemi Shin and Lee, \{Jin Ku\} and Zhaoqi Liu and Raul Rabadan and Jeongwu Lee and Jihye Shin and Cheolju Lee and Heekyoung Yang and Donggeon Kim and Kim, \{Sung Heon\} and Jooyeon Kim and Oh, \{Jeong Woo\} and Kong, \{Doo Sik\} and Lee, \{Jung Il\} and Seol, \{Ho Jun\} and Choi, \{Jung Won\} and Kang, \{Hyun Ju\} and Nam, \{Do Hyun\}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = nov,

doi = "10.1038/s12276-020-00517-3",

language = "English",

volume = "52",

pages = "1869",

journal = "Experimental and Molecular Medicine",

issn = "1226-3613",

publisher = "Springer Nature",

number = "11",

}

Han, S, Shin, H, Lee, JK, Liu, Z, Rabadan, R, Lee, J, Shin, J, Lee, C, Yang, H, Kim, D, Kim, SH, Kim, J, Oh, JW, Kong, DS , Lee, JI , Seol, HJ , Choi, JW, Kang, HJ & Nam, DH 2020, 'Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)', Experimental and Molecular Medicine, vol. 52, no. 11, pp. 1869. https://doi.org/10.1038/s12276-020-00517-3

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y). / Han, Suji; Shin, Hyemi; Lee, Jin Ku et al.
In: Experimental and Molecular Medicine, Vol. 52, No. 11, 11.2020, p. 1869.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)

AU - Han, Suji

AU - Shin, Hyemi

AU - Lee, Jin Ku

AU - Liu, Zhaoqi

AU - Rabadan, Raul

AU - Lee, Jeongwu

AU - Shin, Jihye

AU - Lee, Cheolju

AU - Yang, Heekyoung

AU - Kim, Donggeon

AU - Kim, Sung Heon

AU - Kim, Jooyeon

AU - Oh, Jeong Woo

AU - Kong, Doo Sik

AU - Lee, Jung Il

AU - Seol, Ho Jun

AU - Choi, Jung Won

AU - Kang, Hyun Ju

AU - Nam, Do Hyun

PY - 2020/11

Y1 - 2020/11

N2 - After online publication of this article, the authors noticed an error in the Acknowledgments section. The correct statement in this article should have read as follows. “The biospecimens for this study were provided by the Samsung Medical Center BioBank. This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3418); the National Research Foundation funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea (NRF-2015M3C9A1044522 and NRF-2018R1C1B3001648); and the intramural research fund of Ajou University Medical Center (2018).” The authors apologize for any inconvenience caused.

AB - After online publication of this article, the authors noticed an error in the Acknowledgments section. The correct statement in this article should have read as follows. “The biospecimens for this study were provided by the Samsung Medical Center BioBank. This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3418); the National Research Foundation funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea (NRF-2015M3C9A1044522 and NRF-2018R1C1B3001648); and the intramural research fund of Ajou University Medical Center (2018).” The authors apologize for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85094973558

U2 - 10.1038/s12276-020-00517-3

DO - 10.1038/s12276-020-00517-3

M3 - Comment/debate

C2 - 33149237

AN - SCOPUS:85094973558

SN - 1226-3613

VL - 52

SP - 1869

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

IS - 11

ER -

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target (Experimental & Molecular Medicine, (2019), 51, 12, (1-11), 10.1038/s12276-019-0351-y)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this